Toxins | |
Genetics, Genomics and Evolution of Ergot Alkaloid Diversity | |
Carolyn A. Young5  Christopher L. Schardl3  Daniel G. Panaccione4  Simona Florea3  Johanna E. Takach5  Nikki D. Charlton5  Neil Moore1  Jennifer S. Webb2  Jolanta Jaromczyk2  | |
[1] Computer Science Department, University of Kentucky, Lexington, KY 40546, USA; E-Mail:;Advanced Genetic Technologies Center, University of Kentucky, Lexington, KY 40546, USA; E-Mails:;Department of Plant Pathology, University of Kentucky, Lexington, KY 40546, USA; E-Mails:;Division of Plant and Soil Sciences, West Virginia University, Morgantown, WV 26506, USA; E-Mail:;Forage Improvement Division, The Samuel Roberts Noble Foundation, Ardmore, OK 73401, USA; E-Mails: | |
关键词:
|
|
DOI : 10.3390/toxins7041273 | |
来源: mdpi | |
【 摘 要 】
The ergot alkaloid biosynthesis system has become an excellent model to study evolutionary diversification of specialized (secondary) metabolites. This is a very diverse class of alkaloids with various neurotropic activities, produced by fungi in several orders of the phylum Ascomycota, including plant pathogens and protective plant symbionts in the family Clavicipitaceae. Results of comparative genomics and phylogenomic analyses reveal multiple examples of three evolutionary processes that have generated ergot-alkaloid diversity: gene gains, gene losses, and gene sequence changes that have led to altered substrates or product specificities of the enzymes that they encode (neofunctionalization). The chromosome ends appear to be particularly effective engines for gene gains, losses and rearrangements, but not necessarily for neofunctionalization. Changes in gene expression could lead to accumulation of various pathway intermediates and affect levels of different ergot alkaloids. Genetic alterations associated with interspecific hybrids of
【 授权许可】
CC BY
© 2015 by the authors; licensee MDPI, Basel, Switzerland.
【 预 览 】
Files | Size | Format | View |
---|---|---|---|
RO202003190014390ZK.pdf | 2908KB | download |